Skip to content
Live news Screener Coverage Pricing Docs REST API WebSocket API MCP server Company Use cases Blog Changelog Status Compare Contact
AXON$422.00+7.40(+1.78%)Axon Announces Body 5: Next-Generation Camera Built for the AI Era Axon (Nasdaq: AXON), the global leader in public safety technology, today announced Axon Body 5, its newest body-worn camera designed to bring more...[1:00:00 PM ET]PFE$30.02-0.40(-1.31%)Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026[11:18:00 AM ET]BIVI$1.24-0.04(-3.13%)From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television[10:30:00 AM ET]AMGN$439.26-8.02(-1.79%)IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's...[10:30:00 AM ET]JNJ$263.81-3.80(-1.42%)Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of...[8:54:00 AM ET]PBLS$24.79-2.13(-7.91%)Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors[8:45:00 AM ET]SMTC$131.80+6.68(+5.34%)Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026[8:00:00 AM ET]GMAB$43.85+3.85(+9.63%)Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]INCY$115.00-1.93(-1.65%)Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]NBTX$29.36+0.17(+0.58%)NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma[7:00:00 AM ET]ONC$377.63-4.64(-1.21%)BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026[4:15:00 AM ET]CMPX$0.77-0.03(-3.97%)Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026[4:15:00 AM ET]CELC$63.20-2.37(-3.61%)Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026[4:15:00 AM ET]

HAS · NASDAQ

Hasbro, Inc.

$117.60 0.00 (0.00%)

Company overview

Hasbro, Inc., together with its subsidiaries, operates as a play and entertainment company. Its Consumer Products segment engages in the sourcing, marketing, and sale of toy and game products, including action figures, arts and crafts, fashion and other dolls, play sets, preschool toys, plush products, sports action blasters and accessories, vehicles, and games. This segment also promotes its brands through the out-licensing of trademarks, characters, and intellectual property rights to third parties for branded consumer products such as apparel, publishing, home goods, electronics, and toys. The company's Wizards of the Coast and Digital Gaming segment develops trading card, role-playing, and digital game experiences based on Hasbro and Wizards of the Coast games.

Sector
Consumer Cyclical
Industry
Leisure
Exchange
NASDAQ
Market cap
$16.6B
Employees
4,985
Headquarters
Pawtucket, RI
CEO
Christian Cocks
Listed
March 17, 1980
P/E
-73.50
Dividend yield
3.00%

Company financials

Revenue
$4.8B
Gross profit
$3.4B
Operating income
$1.2B
EBITDA
$283M
Net income
-$222M
EPS
-$1.60
Total assets
$5.9B
Total debt
$3.9B
Gross margin
69.79%
Net margin
-4.60%
Earnings yield
-1.36%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

73.4984.9896.48107.98119.47
HAS 1D NASDAQ O116.51H117.77L115.22C117.44+0.21 (+0.18%)Vol2.77M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
Ticker Type Headline Source Published
HAS Stock news Why Hasbro Stock Surged This Week The Motley Fool
HAS Stock news Hasbro (HAS) Is Up 5.83% in One Week: What You Should Know Zacks Investment Research
HAS Stock news Best Momentum Stock to Buy for October 23rd Zacks Investment Research
HAS Stock news Best Income Stocks to Buy for October 23rd Zacks Investment Research
HAS Stock news New Strong Buy Stocks for October 23rd Zacks Investment Research
HAS Stock news The Biggest Price Hike in 49 Years Just Hit a Christmas Staple — and Families Could Feel It This Holiday Season 24/7 Wall Street
HAS Press release Outside Big Tech, Tuesday's Earnings Winners Jumped as Much as 11% Stock Preachers News Commentary - Tuesday's session showed how quickly market leadership can change hands. The Dow Jones Industrial Average climbed... PR Newswire
HAS Stock news Toy Prices Are Climbing, And This Toymaker Trades In A Buy Zone Investors Business Daily
HAS Stock news Stay Ahead of the Game With Hasbro (HAS) Q3 Earnings: Wall Street's Insights on Key Metrics Zacks Investment Research
HAS Stock news Hasbro Gears Up for Q3 Earnings: Will MAGIC Drive Growth? Zacks Investment Research
HAS Stock news Hasbro Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call Benzinga
HAS Press release Hasbro's Women Innovators of Play Opens Fourth Annual Design Challenge and Expands Program with New In-Person Event Series GlobeNewswire
HAS Stock news What Hays (HAS) Said on Its Q1 Earnings Call MarketBeat
HAS Stock news Toy Stocks To Watch Now – October 10th Defense World
HAS Press release Hasbro Celebrates Official Opening of Wizards of the Coast Studios in Montréal GlobeNewsWire
HAS Stock news 4 Dividends That Have Not Been Raised in Years and Are Still Worth Owning 247 Wallst
HAS Stock news Why Hasbro (HAS) Could Beat Earnings Estimates Again Zacks Investment Research
HAS Stock news Hasbro (HAS) Surpasses Market Returns: Some Facts Worth Knowing Zacks Investment Research
HAS Stock news Hobby Boom or Travel Bust? Here Are 3 Stocks to Ride the Trend MarketBeat
HAS Press release Hasbro to Announce Third Quarter 2026 Earnings on October 20, 2026 Business Wire
FAQ

Questions about Hasbro, Inc.

What does Hasbro, Inc. do?
Hasbro, Inc., together with its subsidiaries, operates as a play and entertainment company. Its Consumer Products segment engages in the sourcing, marketing, and sale of toy and game products, including action figures, arts and crafts, fashion and other dolls, play sets, preschool toys, plush products, sports action blasters and accessories, vehicles, and games. This segment also promotes its brands through the out-licensing of trademarks, characters, and intellectual property rights to third parties for branded consumer products such as apparel, publishing, home goods, electronics, and toys. The company's Wizards of the Coast and Digital Gaming segment develops trading card, role-playing, and digital game experiences based on Hasbro and Wizards of the Coast games.
What is HAS's market cap?
Hasbro, Inc. (HAS) is a listed stock with a live quote. The latest market cap on this page is $16.6B.
Where is Hasbro, Inc. headquartered?
Hasbro, Inc. is headquartered in Pawtucket, RI.
How do I get HAS news from the API?
Call GET /v1/news?tickers=HAS. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does HAS news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for HAS, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the HAS price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 2,000 REST requests a day. Paid Pro removes the daily cap. If you don't subscribe, the account stays on Free.